Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10108-10114
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10108
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10108
Figure 1 Receiver operating characteristic curve.
Receiver operating characteristic curve for differentiating fibrosis stage 4 based on albumin, platelet, and AAR; aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio. PLALA score (platelet, albumin, AAR).
Figure 2 The percentage of patients with cirrhosis.
The percentage of patients with cirrhosis (stage 4) with a platelet < 15.3 ×104/μL, albumin < 4.0 g/dL, and alanine aminotransferase ratio; aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AAR) > 0.9.
Figure 3 PLALA score and fibrosis stage of 1048 biopsy-proven nonalcoholic fatty liver disease patients.
- Citation: Kessoku T, Ogawa Y, Yoneda M, Imajo K, Sumida Y, Eguchi Y, Fujii H, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Chayama K, Tanaka S, Fujimoto K, Anzai K, Saibara T, Sata M, Itoh Y, Nakajima A, (JSG-NAFLD) TOJSGON. Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(29): 10108-10114
- URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10108.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10108